Muscarinic receptor antagonists.
Watson
N
N
Neurobiology Unit, Roche Bioscience, R2-101, 3401 Hillview Avenue, Palo Alto, California, USA94303,
Eglen
R M
RM
D000402:Airway Obstruction / Q000188:drug therapy / Q000503:physiopathology; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001570:Benzodiazepinones / Q000494:pharmacology / Q000627:therapeutic use; D001980:Bronchi / Q000187:drug effects* / Q000378:metabolism; D005703:Gallamine Triethiodide / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D018727:Muscarinic Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D014132:Trachea / Q000187:drug effects* / Q000378:metabolism
D001570:Benzodiazepinones; D018727:Muscarinic Antagonists; D010880:Piperidines; C069054:AQ-RA 741; D005703:Gallamine Triethiodide